Ardelyx's constipation drug succeeds in late-stage trial

(Reuters) - Ardelyx Inc said on Wednesday a second late-stage trial of its experimental drug for irritable bowel syndrome with constipation (IBS-C) met the main goal of reducing abdominal pain and increasing bowel movement.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news